If you are building AI features for a bank, a hospital, or a government agency, the hard part is not the model. It is everything around the model. Here are the architecture decisions that separate systems that ship from systems that get pulled in audit.
1. Provenance has to be a first-class data structure. You will be asked "where did this answer come from?" — by a regulator, a compliance officer, or a plaintiff's lawyer. Design for it. Every inference should be traceable to the model version, the prompt, the retrieved context, and the data sources that trained the underlying model. California's AB 2013 already requires training-data disclosure for clinical decision support AI; the EU AI Act enforces similar provenance obligations across the bloc by August 2027. If you cannot reconstruct an answer's lineage on demand, you are not production-ready in a regulated context.
2. Human-in-the-loop is an architectural pattern, not a checkbox. Fully autonomous decisions in credit, clinical, or benefits-eligibility contexts invite the highest regulatory scrutiny. The pattern that wins: agents that recommend, with structured checkpoints where a human reviews edge cases. Build the queue, the override path, and the audit log for human decisions as core infrastructure, not as a v2 feature.
3. Hybrid agents beat monolithic models. A 70B-parameter model is overkill for fraud labeling, and the cost-per-decision math kills projects that ignore this. The architecture that scales is a small reasoning model orchestrating specialist tools — a fraud scorer, a KYC checker, a ledger writer — each independently testable and replaceable. This also makes bias testing tractable: you can audit each tool, not one opaque giant.
4. Observability is the gate, not a nice-to-have. If you cannot answer "what did this system do last Tuesday at 3pm and why," you cannot deploy it in a regulated workflow. Treat the observability layer — request logs, decision traces, drift metrics, incident timelines — as a launch requirement equal to the feature itself.
5. Plan for the operations cost from day one. Production AI needs monitoring, retraining, drift detection, and incident response. Teams that scope only the build phase blow their timelines when the operations reality hits. And accreditation — FedRAMP, HIPAA, SOC 2, equivalents — adds four to nine months on average. Your engineering roadmap and your accreditation roadmap are now the same document.
The market context, if you need it for a business case: AI in fintech is headed for ~$66.5B by 2030, AI in healthcare for $505.59B by 2033, and ~90% of US federal agencies are already adopting or planning AI. Enterprise AI ROI averages 171% (192% for US firms), but only about 5% of enterprises capture most of the value — and the differentiator is iteration speed, not budget.
If you want the full landscape — sector-by-sector forecasts, the EU AI Act timeline, real deployments from Klarna, JPMorgan, and Singapore's VICA, and a build-buy-partner decision framework — there is this breakdown of AI across fintech, healthtech, and govtech that goes deeper.
The build-vs-buy-vs-partner call: build in-house only for the IP that differentiates you (the talent ramp is 18-24 months), buy off-the-shelf for generic capabilities like transcription and search, and partner for the high-stakes regulated workflows where you need someone who has shipped the exact pattern before.
Top comments (0)